$11.20
7.44% today
Nasdaq, Aug 12, 07:40 pm CET
ISIN
US71716E1055
Symbol
PHAR

Pharming Group N.V. - ADR Stock price

$12.10
+2.10 21.00% 1M
+3.54 41.36% 6M
+2.04 20.22% YTD
+4.48 58.79% 1Y
+1.36 12.66% 3Y
-4.60 27.54% 5Y
-4.60 27.54% 10Y
-4.60 27.54% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-1.13 8.54%
ISIN
US71716E1055
Symbol
PHAR
Industry

Key metrics

Basic
Market capitalization
$813.5m
Enterprise Value
$815.8m
Net debt
$2.3m
Cash
$126.0m
Shares outstanding
685.2m
Valuation (TTM | estimate)
P/E
negative | 606.8
P/S
2.4 | 2.4
EV/Sales
2.4 | 2.4
EV/FCF
27.1
P/B
3.4
Financial Health
Equity Ratio
55.3%
Return on Equity
-5.4%
ROCE
6.8%
ROIC
-
Debt/Equity
0.5
Financials (TTM | estimate)
Revenue
$339.8m | $335.5m
EBITDA
$40.2m | $-6.5m
EBIT
$24.5m | $-19.8m
Net Income
$-8.2m | $13.7m
Free Cash Flow
$30.1m
Growth (TTM | estimate)
Revenue
22.4% | 12.9%
EBITDA
10,975.7% | -187.1%
EBIT
249.0% | -450.7%
Net Income
38.5% | 215.4%
Free Cash Flow
560.7%
Margin (TTM | estimate)
Gross
89.3%
EBITDA
11.8% | -1.9%
EBIT
7.2%
Net
-2.4% | 4.1%
Free Cash Flow
8.9%
More
EPS
$0.0
FCF per Share
$0.0
Short interest
-
Employees
404
Rev per Employee
$740.0k
Show more

Is Pharming Group N.V. - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Pharming Group N.V. - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Pharming Group N.V. - ADR forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Pharming Group N.V. - ADR forecast:

Buy
93%
Hold
7%

Financial data from Pharming Group N.V. - ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
340 340
22% 22%
100%
- Direct Costs 36 36
14% 14%
11%
304 304
23% 23%
89%
- Selling and Administrative Expenses 197 197
2% 2%
58%
- Research and Development Expense 86 86
18% 18%
25%
40 40
10,976% 10,976%
12%
- Depreciation and Amortization 16 16
2% 2%
5%
EBIT (Operating Income) EBIT 25 25
249% 249%
7%
Net Profit -8.20 -8.20
38% 38%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Pharming Group N.V. - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pharming Group N.V. - ADR Stock News

Neutral
Seeking Alpha
11 days ago
Pharming Group N.V. (NASDAQ:PHAR ) Q2 2025 Earnings Conference Call July 31, 2025 7:30 AM ET Executives Anurag Relan – Chief Medical Officer Fabrice Chouraqui – CEO & Executive Director Stephen Toor – Chief Commercial Officer & GM Americas Analysts Benjamin Jackson - Jefferies Jeffrey Michael Jones - Oppenheimer & Co. Inc., Research Division Simon Scholes - First Berlin Equity Research GmbH Sus...
Neutral
GlobeNewsWire
2 months ago
Leiden, the Netherlands, June 11, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all proposals were approved.
Neutral
Seeking Alpha
3 months ago
Pharming Group N.V. (NASDAQ:PHAR ) Q1 2025 Earnings Conference Call May 8, 2025 7:30 AM ET Company Participants Fabrice Chouraqui – CEO Stephen Toor – CCO Anurag Relan - Chief Medical Officer Jeroen Wakkerman - CFO Conference Call Participants Jeff Jones – Oppenheimer Joe Pantginis - H.C.
More Pharming Group N.V. - ADR News

Company Profile

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.

Head office Netherlands
CEO Fabrice Chouraqui
Employees 404
Founded 1988
Website www.pharming.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today